In one report, 15-LOX-1 reexpression in PC-3 prostate cancer cells increased expression of vascular endothelial growth factor (VEGF) in vitro and increased angiogenesis in subcutaneous xenografts 22. This evidence concerns the gene OLR1 and prostate carcinoma.